Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1

被引:176
作者
Contarino, A
Dellu, F
Koob, GF
Smith, GW
Lee, KF
Vale, W
Gold, LH
机构
[1] Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA
[2] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA
关键词
CRF receptor type 1; null mutant mice; anxiety; memory;
D O I
10.1016/S0006-8993(98)01158-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Corticotropin-releasing factor (CRF) has been hypothesized to be involved in the pathophysiology of anxiety, depression, cognitive and feeding disorders. Two distinct CRF receptor subtypes, CRFR1 and CRFR2, are thought to mediate CRF actions in the CNS. However, the role for each receptor subtype in animal models of neuropsychiatric disorders remains to be determined. Using CRFR1 deficient mice, the present study investigated the functional significance of this CRF receptor subtype in anxiety-like and memory processes. CRFR1 knockout mice displayed an increased exploratory behavior in both the Elevated Plus-maze (EPM) and the Black and White (B-W) test box models of anxiety, indicating an anxiolytic-like effect of the CRFR1 gene deletion. In contrast, during the retrieval trial of a two-trial spatial memory task wild type mice made more visits to and spent more time in the novel arm as opposed to the two familiar ones of a Y-maze apparatus. No increase in the level of exploration of the novel arm by the CRFR1 deficient mice was observed. This indicates that CRFR1 knockout mice are impaired in spatial recognition memory. These results demonstrate that genetic deletion of the CRFR1 receptor can lead to impairments in anxiety-like and cognitive behaviors, supporting a critical role for this receptor in anxiety and cognitive biological processes. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 52 条
[1]   CRF ANTAGONIST REVERSES THE ANXIOGENIC RESPONSE TO ETHANOL WITHDRAWAL IN THE RAT [J].
BALDWIN, HA ;
RASSNICK, S ;
RIVIER, J ;
KOOB, GF ;
BRITTON, KT .
PSYCHOPHARMACOLOGY, 1991, 103 (02) :227-232
[2]   DISPLACEMENT OF CORTICOTROPIN-RELEASING FACTOR FROM ITS BINDING-PROTEIN AS A POSSIBLE TREATMENT FOR ALZHEIMERS-DISEASE [J].
BEHAN, DP ;
HEINRICHS, SC ;
TRONCOSO, JC ;
LIU, XJ ;
KAWAS, CH ;
LING, N ;
DESOUZA, EB .
NATURE, 1995, 378 (6554) :284-287
[3]  
Behan DP, 1996, MOL PSYCHIATR, V1, P265
[4]   CRF AND RESTRAINT-STRESS DECREASE EXPLORATORY-BEHAVIOR IN HYPOPHYSECTOMIZED MICE [J].
BERRIDGE, CW ;
DUNN, AJ .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 34 (03) :517-519
[5]   DEXAMETHASONE SUPPRESSES PITUITARY-ADRENAL BUT NOT BEHAVIORAL-EFFECTS OF CENTRALLY ADMINISTERED CRF [J].
BRITTON, DR ;
VARELA, M ;
GARCIA, A ;
ROSENTHAL, M .
LIFE SCIENCES, 1986, 38 (03) :211-216
[6]   ACTIVATING AND ANXIOGENIC EFFECTS OF CORTICOTROPIN RELEASING-FACTOR ARE NOT INHIBITED BY BLOCKADE OF THE PITUITARY-ADRENAL SYSTEM WITH DEXAMETHASONE [J].
BRITTON, KT ;
LEE, G ;
DANA, R ;
RISCH, SC ;
KOOB, GF .
LIFE SCIENCES, 1986, 39 (14) :1281-1286
[7]   CORTICOTROPIN RELEASING-FACTOR (CRF) RECEPTOR ANTAGONIST BLOCKS ACTIVATING AND ANXIOGENIC ACTIONS OF CRF IN THE RAT [J].
BRITTON, KT ;
LEE, G ;
VALE, W ;
RIVIER, J ;
KOOB, GF .
BRAIN RESEARCH, 1986, 369 (1-2) :303-306
[8]  
BUTLER PD, 1990, J NEUROSCI, V10, P176
[9]  
CHALMERS DT, 1995, J NEUROSCI, V15, P6340
[10]   EXPRESSION CLONING OF A HUMAN CORTICOTROPIN-RELEASING-FACTOR RECEPTOR [J].
CHEN, RP ;
LEWIS, KA ;
PERRIN, MH ;
VALE, WW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (19) :8967-8971